News

Pharmabiz1d
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA: Shardul Nautiyal, Mumbai Saturday, August 2, 2025, 08:00 Hrs [IST] US President Donald Trumps ...
Pharmabiz1d
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [I ...
Pharmabiz1d
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence: Gireesh Babu, New Delhi Saturday, August 2, 2025, 08:00 Hrs [IST] The Union ...
Pharmabiz1d
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [IST] Karnataka governme ...
Pharmabiz2d
P&G to invest over Rs. 2,000 crore in Gujarat for psyllium-based laxative manufacturing plant: Dr. H.G. Koshia
P&G to invest over Rs. 2,000 crore in Gujarat for psyllium-based laxative manufacturing plant: Dr. H.G. Koshia: Shardul Nautiyal, Mumbai Friday, August 1, 2025, 08:00 Hrs [IST] In ...
Pharmabiz1d
R Lalvena IAS appointed new director of TN DC department
The Department of Drug Control Administration (DCA) in Tamil Nadu has once again come under the direct leadership of an IAS officer, R Lalvena, following the recent arrest of its former director, P U ...
Pharmabiz2d
US duty impact for Indian medical devices sector to be seen from relative competitiveness: AiMeD
US duty impact for Indian medical devices sector to be seen from relative competitiveness: AiMeD: Our Bureau, New Delhi Friday, August 1, 2025, 08:00 Hrs [IST] The industry needs ...
Pharmabiz2d
New office-bearers elected for TN IPA, unveils ambitious plans to elevate pharmacy standards
New office-bearers elected for TN IPA, unveils ambitious plans to elevate pharmacy standards: Peethaambaran Kunnathoor, Chennai Friday, August 1, 2025, 08:00 Hrs [IST] The Tamil N ...
Pharmabiz2d
Karnataka issues order to merge Ayush drug dept with State FDA
Karnataka issues order to merge Ayush drug dept with State FDA: Nandita Vijayasimha, Bengaluru Friday, August 1, 2025, 08:00 Hrs [IST] Karnataka government has issued order on the ...
Pharmabiz2d
PESB calls for applications to the post of MD of BCPL
The Public Enterprises Selection Board (PESB) has called for applications from eligible candidates for appointment of the managing director of Public Sector Undertaking (PSU) Bengal Chemicals and ...
Pharmabiz1d
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients: Miami Saturday, August 2, 2025, 18:00 Hrs [IST] Pasith ...
Pharmabiz1d
Medicenna strengthens IP portfolio with five patents granted for its IL-2 and IL-4 Superkines
US Patent No. 12,202,873 – Superagonists, Partial Agonists and Antagonists of IL-2. Also granted in Switzerland, China, Germany, France, United Kingdom, India, and Japan and allowed in Canada with ...